LOKELMA 5 g/5g
sodium zirconium cyclosilicate · POWDER, FOR SUSPENSION · AstraZeneca Pharmaceuticals LP
LOKELMA is a powder, for suspension containing sodium zirconium cyclosilicate at 5 g/5g, taken oral. Manufactured by AstraZeneca Pharmaceuticals LP.
Key Facts
- Brand Name
- LOKELMA
- Generic Name
- sodium zirconium cyclosilicate
- NDC Code (Product)
0310-1105- Manufacturer
- AstraZeneca Pharmaceuticals LP
- Strength
- 5 g/5g
- Dosage Form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Marketing Status
- Application #
- NDA207078
- Marketing Start
- 09/04/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is LOKELMA used for?
LOKELMA contains sodium zirconium cyclosilicate. It is a powder, for suspension taken oral. Consult your doctor for specific uses.
Is LOKELMA a controlled substance?
LOKELMA is not classified as a controlled substance by the DEA.
What is the generic name for LOKELMA?
The generic name for LOKELMA is sodium zirconium cyclosilicate. There are no other listed brand versions of sodium zirconium cyclosilicate.
What is the NDC code for LOKELMA 5 g/5g?
The NDC (National Drug Code) for LOKELMA 5 g/5g is 0310-1105, listed by AstraZeneca Pharmaceuticals LP.
Other LOKELMA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)